Onconova Therapeutics Inc Extraordinary Shareholders Meeting Transcript
Good afternoon, and welcome to the Reconvened Special Meeting of Stockholders for Onconova Therapeutics, Inc. I would now like to turn the meeting over to Dr. Steven Fruchtman, President and CEO of Onconova. Dr. Fruchtman, please go ahead.
Thank you, and good afternoon, ladies and gentlemen. Will the meeting please come to order. As we reported on March 4, 2021, before the meeting was adjourned, there is a quorum present for the transaction of business.
The next order of business is a description of the proposals to be voted on at today's meeting. Proposal #1, Reverse Stock Split. This proposal is to consider and vote upon an amendment to our Tenth Amended and Restated Certificate of Incorporation, as amended, to combine outstanding shares of our common stock into a lesser number of outstanding shares or a reverse stock split by a ratio of not less than 1-for-5 and not more than 1-for-15, with the exact ratio to be set within this range by our Board of Directors in its
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |